Thursday, July 14, 2011

SMALL TYROSINE KINASE INHIBITORS OR MONOCLONAL ANTIBODIES TO EGFR.. LESS SIDE EFFECTS? WHY?

which type of drug, small tyrosine kinase inhibitors or monoclonal antibodies to EGFR, would you predict to have less adverse side effects and why?
Posted by Ewa Fotopoulos at 11:08 AM

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)